In a breakthrough for health care, Kozhikode has become the first district in Kerala to provide continuous glucose monitoring (CGM) systems free of charge to children diagnosed with Type 1 Diabetes (T1D)...
Indian Council of Medical Research (ICMR), along with Regional Medical Research Centre, Bhubaneswar (RMRCBB) and National Institute of Malaria Research (NIMR) is leading the formulation of a new indigenous malaria vaccine called AdFalciVax.
Torrent Pharmaceuticals has sought the Competition Commission of India (CCI) clearance for its planned ?19,500 crore acquisition of a majority holding in JB Chemicals & Pharmaceuticals.
Venus Remedies Limited (NSE: VENUSREM, BSE: 526953), a leading research-driven pharmaceutical company, has once again received the World Health Organization (WHO) Good Distribution Practices (GDP)
Biocon Biologics has announced US FDA approval for Kirsty (Insulin Aspart-xjhz, 100 units/mL). It's an extremely important development as Kirsty is the first and only interchangeable biosimilar to NovoLog, a rapid-acting insulin brand...
The Central Drugs Standard Control Organisation (CDSCO) further prolonged the deadline for pharma firms to file online applications for the WHO Good Manufacturing Practices (GMP) Certificate of Pharmaceutical Product (COPP) to August 15, 2025.
The critical momentum to the biomanufacturing sector in India is being spurred by the fact that Danaher India, a subsidiary of world science and technology giant Danaher Corporation, has entered into a strategic alliance with the Translational Health
The InfinityLab Pro iQ Series mass detectors were launched by Agilent Technologies in India. The series is designed for next-generation liquid chromatography-mass detection (LC-MS) and aims to improve how impurities, trace contaminants, and complex
Apollo Home Healthcare in collaboration with the Apollo Indraprastha Hospitals has launched a integrated palliative care at home service in New Delhi. This is a ground breaking step towards meeting the increasing demands for compassionate...
Pharma company Corona Remedies is set to further bolster its presence in cardiology and hormones for women with seven major brands purchased from Bayer's Indian pharmaceuticals division. The acquisition would take effect on July 16, 2025, and is...